February 2026
The global rare cell isolation market size was estimated at USD 2.25 billion in 2025 and is expected to hit around USD 5.63 billion by 2035, growing at a CAGR of 9.61% from 2026 to 2035.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global extracellular vesicles-based liquid biopsy market size is evaluated at USD 122.72 million in 2025 and is predicted to hit around USD 152.88 million by 2035, growing at a CAGR of 2.47%.
June 2026
The global cellulose-reinforced hydrogels market size is evaluated at USD 1.44 billion in 2025 and is predicted to hit around USD 2.78 billion by 2035, growing at a CAGR of 6.80%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global peripheral blood mononuclear cells market size was evaluated at USD 317.35 billion in 2025 and is predicted to hit around USD 842.89 billion by 2035, growing at a CAGR of 10.26%.
June 2026
The US cell and gene therapy market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 20.00 billion by 2035, growing at a CAGR of 17.21%.
June 2026
The global cell encapsulation technology market is growing as regenerative medicine and cell therapies adopt protective encapsulation techniques.
June 2026
The global natural killer (NK) cell therapeutics market size was evaluated at USD 477.10 million in 2025 and is predicted to hit around USD 12,316.96 million by 2035, growing at a CAGR of 38.42%.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global in vivo cell reprogramming market is expanding as regenerative medicine advances toward direct in-body cell conversion for tissue repair and disease treatment.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global human primary cell culture market size was estimated at USD 4.33 billion in 2025 and is expected to hit around USD 12.21 billion by 2035, growing at a CAGR of 10.92% from 2026 to 2035.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The global single-cell genomics market is growing as advanced sequencing technologies enable high-resolution analysis of individual cells.
June 2026
The global cell surface marker detection market size is estimated to hit around USD 13.76 billion by 2035, increasing from USD 6.16 billion in 2025, with a CAGR of 8.37%.
June 2026
The global image-based cytometry in cell analysis market size is accounted to hit around USD 9.78 billion by 2035 increasing from USD 3.68 billion in 2025, with a CAGR of 10.27%.
June 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
June 2026
The US CAR T-cell therapy market size was evaluated at USD 2,299.97 million in 2025 and is predicted to hit around USD 11,510.04 million by 2035, growing at a CAGR of 17.47%.
June 2026
The global pharmaceutical impurity synthesis and isolation services market size was valued at USD 1.35 billion in 2025 and is expected to hit around USD 2.93 billion by 2035, at a CAGR of 8.06%.
June 2026
The global induced pluripotent stem cells market size is estimated to hit around USD 5.57 billion by 2035, increasing from USD 2.13 billion in 2025, with a CAGR of 10.09%.
June 2026
The global single cell sequencing market size is estimated to hit around USD 11.09 billion by 2035, increasing from USD 2.82 billion in 2025, with a CAGR of 14.67%.
June 2026
The global stem cell therapy for neurological disorders market size was evaluated at USD 2.38 billion in 2025 and is predicted to hit around USD 12.67 billion by 2035, growing at a CAGR of 17.90%.
June 2026
The global cell therapy manufacturing market size was valued at USD 5.55 billion in 2025 and is projected to hit around USD 21.02 billion by 2035 with a CAGR of 14.24%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The U.S. cell therapy manufacturing market size was evaluated at USD 1.71 billion in 2025 and is predicted to hit around USD 6.56 billion by 2035, growing at a CAGR of 14.39%.
June 2026
The global circulating tumor cells market size was evaluated at USD 14.68 billion in 2025 and is predicted to hit around USD 54.76 billion by 2035, growing at a CAGR of 14.07%.
June 2026
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.18%.
June 2026
The global cell cryopreservation market size is valued at USD 1,640.9 million in 2025 and is projected to hit around USD 5,028.90 million by 2035 with a CAGR of 11.85%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com